Try our Advanced Search for more refined results
October 29, 2010
ELI LILLY AND COMPANY v. TEVA PARENTERAL MEDICINES, INC. et al
Case Number:
1:10-cv-01376
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 25, 2015
Eli Lilly Scores Win Over Teva In Alimta Patent Fight
An Indiana federal judge on Tuesday ruled that Teva Parenteral Medicines Inc.'s proposed labeling for a generic version of the cancer drug Alimta would cause physicians to infringe Eli Lilly & Co.'s vitamin-regimen patent.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login